News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines emerged in the past hour across equities, bonds, FX, or commodities.
  • Global stock indices showed limited movement with low volume and no clear directional catalyst.
  • There were no central bank announcements or significant economic data releases during the hour.
  • No new geopolitical events or sudden risk events were reported to impact markets.
  • Corporate earnings calendars had no surprise filings or large-cap shocks in the past hour.
  • Liquidity and volatility remained muted, suggesting limited trade opportunities for short-term traders.

Latest Articles

TON Strategy Company Highlights TON Upgrade Establishing Network-Level Infrastructure for Telegram’s Native Gram Wallet

TON Strategy Company Highlights TON Upgrade Establishing Network-Level Infrastructure for Telegram’s Native Gram Wallet

TON Strategy Company, a Nasdaq-listed digital asset treasury firm, voted in favor of two key upgrades to The Open Network (TON) blockchain: Config -123, introducing a scalable smart contract architecture for Telegram's native Gram Wallet, and Config 30, improving network throughput by extending validator leader windows. These upgrades aim to stream…

SCYNEXIS to Participate in Upcoming Investor Conferences

SCYNEXIS to Participate in Upcoming Investor Conferences

SCYNEXIS, Inc., a clinical-stage biotechnology company specializing in innovative therapies for severe diseases, announced its participation in the 12th Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company will hold a fireside chat and one-on-one investor meetings, with a webcast availabl…

Biomerica Reports Fiscal 2026 Year-End Financial Results

Biomerica Reports Fiscal 2026 Year-End Financial Results

Biomerica, Inc. reported its fiscal year 2026 financial results, showing a 17% increase in Q4 net sales, a 24% improvement in full-year net loss, and key commercial advancements including Medicare reimbursement for its inFoods IBS test. The company completed a $2.23 million financing to support ongoing commercialization and strategic initiatives.

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

VivoSim Labs announces development of a rat liver model to complement its existing human liver NAMkind™ platform, aiming to improve drug toxicity testing by differentiating species-specific toxicological effects. This bi-species comparative model is designed to help pharmaceutical companies better assess drug safety and reduce premature termination…

Navitas Delivers Latest Gen 5 GaNFast™ Manufactured in the U.S. Through GlobalFoundries Partnership to Accelerate AI Infrastructure

Navitas Delivers Latest Gen 5 GaNFast™ Manufactured in the U.S. Through GlobalFoundries Partnership to Accelerate AI Infrastructure

Navitas Semiconductor announces the first shipments of its 5th Generation GaNFast™ GaN power semiconductors manufactured domestically at GlobalFoundries' U.S.-based 200mm GaN-on-Si facility. This collaboration strengthens U.S. semiconductor supply chains for critical AI infrastructure, high-performance computing, industrial electrification, and nat…

Aduro Clean Technologies Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Business Update

Aduro Clean Technologies Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Business Update

Aduro Clean Technologies Inc. reported its fourth quarter and fiscal 2026 results highlighting substantial investments in pilot plant operations, engineering, and project development. The company transitioned its Next Generation Process Pilot Plant into structured operations and progressed its First-of-a-Kind program. Aduro strengthened its financi…

Septerna to Participate in Upcoming Investor Conferences

Septerna to Participate in Upcoming Investor Conferences

Septerna, Inc., a clinical-stage biotech focusing on GPCR drug discovery, announced management's participation in two major healthcare investor conferences in September 2026, including live webcasts. The company highlights its proprietary technology platform and diverse pipeline targeting endocrinology, immunology, inflammation, and metabolic disea…

Figure Completes Acquisition of Kiavi

Figure Completes Acquisition of Kiavi

Figure Technology Solutions finalized its acquisition of Kiavi, the leading Residential Transition Loan lender, to enhance its blockchain-based capital marketplace. The integration is expected to broaden access to Kiavi's lending technologies within Figure's extensive ecosystem, accelerating growth in the $35 trillion home equity market. The deal i…

Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President

Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President

Profound Medical Corp., a NASDAQ-listed medical device company specializing in interventional MRI procedures, has appointed Richard Fabian as President. Fabian brings extensive leadership experience in healthcare technology and medical devices, notably from Fujifilm Sonosite and Philips Healthcare. This leadership change aims to enhance the company…

Asure Tax Now Available on Oracle Marketplace

Asure Tax Now Available on Oracle Marketplace

Asure Software, Inc. has made its Asure Tax solution available on Oracle Marketplace, enabling integration with Oracle Fusion Cloud Human Capital Management (HCM). This integration allows enterprises using Oracle's HR platform to add comprehensive payroll tax and treasury capabilities without switching core payroll systems, offering federal, state,…

Scribe Therapeutics to Participate in Upcoming Investor Conferences

Scribe Therapeutics to Participate in Upcoming Investor Conferences

Scribe Therapeutics, a Nasdaq-listed clinical-stage biotech company specializing in in vivo CRISPR therapies, announced management's participation in several investor conferences in September and October 2026. The company focuses on developing genetic medicines aimed at preventing and treating cardiometabolic diseases, with its lead candidate STX-1…